NCT07496359 · RECRUITING

Dyadic Management Intervention in Older People With Co-occurring Cognitive Impairment and Diabetes as a Supplementary Approach to Chronic Diseases Self-Management Program

This trial tests whether a six-week group self-management program, taught to older adults with diabetes and memory concerns alongside their caregivers, improves diabetes self-care and thinking skills. Sessions run weekly for 2.5 hours. It is a behavioral study with no drug, so no phase applies. Researchers also look at how well it works in real-world settings.

You may qualify if

  • Individuals with DM aged >= 55 years old;
  • Recent glycosylated haemoglobin (HbA1c) level of 6.5% or above without change in diabetes medication within the last 3 months based on centre's records;
  • Subjective cognitive decline (using SCDQ21) (separately reported by the patient and/or caregiver) and confirmed by MOCA (Chinese version) screened by the research nurses;
  • Subjects with nominated primary caregivers will be recruited in the intervention group;
  • For caregivers: they will be considered in the project if they have been the primary caregiver for the person for at least 1 year and are providing or involved in the patient's care on a daily basis.

You're excluded if

  • Medical diagnoses of dementia;
  • Those who have terminal illness;
  • For caregivers: those who are temporary caregivers and have only provided/involved in care for less than a year.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-09-17

View full record on ClinicalTrials.gov

All APOE4 clinical trials